Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Recent studies have implicated fatty acid-dependent activation of the serine kinase IKKβ, which plays a key role in tissue inflammation, in the pathogenesis of insulin resistance. High doses of salicylates have recently been shown to inhibit IKKβ activity and might therefore ameliorate insulin resistance and improve glucose tolerance in patients with type 2 diabetes. To test this hypothesis, we studied nine type 2 diabetic subjects before and after 2 weeks of treatment with aspirin (∼7 g/d). Subjects underwent mixed-meal tolerance tests and hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose to assess glucose turnover before and after treatment. High-dose aspirin treatment resulted in a ∼25% reduction in fasting plasma glucose, associated with a ∼15% reduction in total cholesterol and C-reactive protein, a ∼50% reduction in triglycerides, and a ∼30% reduction in insulin clearance, despite no change in body weight. During a mixed-meal tolerance test, the areas under the curve for plasma glucose and fatty acid levels decreased by ∼20% and ∼50%, respectively. Aspirin treatment also resulted in a ∼20% reduction in basal rates of hepatic glucose production and a ∼20% improvement in insulin-stimulated peripheral glucose uptake under matched plasma insulin concentrations during the clamp. In conclusion, these data support the hypothesis that IKKβ represents a new target for treating type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Moreover, the insulin resistance was ameliorated with salicylates, which also protected against insulin resistance in rodents after acute lipid infusion,127 and reversed insulin resistance in people with type 2 diabetes mellitus.128”
From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [128]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Self-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Self-citationMechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052
Self-citation
Research works printed but not linked: 3
- Ebstein, 1877, Berliner Klinische Wochenschrift, 24, 337
- Giugliano, 1982, Diabete Metab, 8, 279
- Shulman, 1990, Am J Physiol, 259, E335
Cited by
Items 401–500 of 554
Effects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus
Molero, J. C., Lee, S., Leizerman, I., Chajut, A., Cooper, A., & Walder, K. R. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.002 · Cited by 10
Specificity of insulin signalling in human skeletal muscle as revealed by small interfering RNA
Krook, A., & Zierath, J. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1330-y · Cited by 10
Emerging Roles for A20 in Islet Biology and Pathology
Zammit, N. W., & Grey, S. T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0398-6_9 · Cited by 11
Fat Metabolism and Diabetes: 2003 American Diabetes Association Postgraduate Course
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2198 · Cited by 11
Kokura, S., Adachi, S., Mizushima, K., Okayama, T., Hattori, T., Okuda, T., Nakabe, N., Manabe, E., Ishikawa, T., Handa, O., et al. (2010) · International Journal of Hyperthermia · doi:10.3109/02656730903272917 · Cited by 9
Mechanisms of Insulin Signal Transduction
Garvey, W. T. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0301 · Cited by 10
Zhang, H., Zeng, Z., Liu, Y., Zheng, W., Wang, J., Yao, Y., Wang, Y., Ji, M., & Hou, P. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01478-1 · Cited by 12
Friberg, J., Tonnesen, M., Heller, S., Pociot, F., Bödvarsdóttir, T., & Karlsen, A. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013341 · Cited by 10
Demirdirek, B., & Uhrich, K. E. (2017) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911517721070 · Cited by 8
Rai, U., Senapati, D., & Arora, M. K. (2022) · Diabetology International · doi:10.1007/s13340-022-00607-9 · Cited by 10
di Palma, A., Matarese, G., Leone, V., Matola, T. D., Acquaviva, F., Acquaviva, A. M., & Ricchi, P. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0473 · Cited by 8
Puder, J. J., Varga, S., Nusbaumer, C., Zulewski, H., Bilz, S., Müller-Stich, B. P., & Keller, U. B. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01734.x · Cited by 9
Mechanisms of insulin signal transduction
Langlais, P. R., Mandarino, L. J., & Garvey, W. T. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch12 · Cited by 11
Ecotoxicity effect of aspirin on the larvae of Musca domestica through retinol metabolism
Li, T., Yin, Y., Zhang, K., Li, Y., Kong, X., Liú, D., Luo, Y., Zhang, R., & Zhong, Z. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115845 · Cited by 8
Yu, J., Liu, C., Li, Z., Zhang, C., Wang, Z., & Liu, X. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.04.013 · Cited by 8
Zhang, X., Gao, Y., Liu, Z., Li, W., Kang, Y., Li, X., Xu, Z., Peng, C. Y., & Qi, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010320 · Cited by 8
Finnegan, C. L., Dicker, P., Asandei, D. R., Higgins, M., O’Gorman, N., Riordan, M. O., Dunne, F., Gaffney, G., Newman, C., McAuliffe, F. M., et al. (2024) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2024.101297 · Cited by 10
Wang, Z., Koonen, D. P. Y., Hofker, M. H., & Bao, Z. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191485 · Cited by 7
RetractedTarantino, G., Citro, V., & Finelli, C. (2014) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.233.gvt · Cited by 9
Ruderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 9
Self-citationZukünftige Angriffspunkte für die Therapie des Typ-2-Diabetes
Stingl, H., & Roden, M. (2004) · Wiener klinische Wochenschrift · doi:10.1007/bf03041051 · Cited by 7
Insulin Resistance in NAFLD: Potential Mechanisms and Therapies
Samuel, V. T., & Shulman, G. I. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch4 · Cited by 7
Self-citationWhite, M. F. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch8 · Cited by 12
Al-Busaidi, A., Alabri, O., Alomairi, J., Elsharaawy, A., Lawati, A. A., Lawati, H. A., & Das, S. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998281910231231051814 · Cited by 9
Zhang, Y., Yu, X., Zhu, J., Liu, S., Liu, X., Dong, Q.-X., Chai, J.-Q., & Liu, R. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.012 · Cited by 6
Mohiuddin, S. S. (2018) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2018.05.00155 · Cited by 8
Chao, R., Li, D., Yue, Z., Huang, C., Kou, Y., Zhou, Q., Gao, Y., Hasegawa, T., Guo, J., & Li, M. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920030098 · Cited by 10
Wieser, V. E., Moschen, A. R., & Tilg, H. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_7 · Cited by 6
Bhatt, B. A., Dedousis, N. L., SIPULA, I. J., & O'Doherty, R. M. (2018) · Physiological Reports · doi:10.14814/phy2.13836 · Cited by 5
Ruderman, N. B., & Shulman, G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00043-3 · Cited by 24
Self-citationNF-κB Pathway in Metabolic/endocrine Diseases
Lee, M., & Kim, K. (2006) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2006.21.5.352 · Cited by 7
Injectable microspheres for extended delivery of bioactive insulin and salicylic acid
Yu, W., Bien‐Aime, S., Li, J., Zhang, L., McCormack, E. S., Goldberg, I. D., Narayan, P., & Uhrich, K. E. (2015) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911515569919 · Cited by 6
The 6th Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb11 · Cited by 6
The Role of PGE2 in Age-related Diseases
Guan, J., Chen, C., Wu, S., & Zhu, H. (2025) · Current Drug Targets · doi:10.2174/0113894501383329250616070727 · Cited by 5
Cellular Mechanisms of Insulin Action
Ciaraldi, T. P. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_5 · Cited by 6
Unintended positive and negative effects of drugs on lipoproteins
Siahmansur, T. J., Schofield, J. D., Azmi, S., Liu, Y., Durrington, P. N., & Soran, H. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000198 · Cited by 8
Role of de novo lipogenesis in insulin resistance in first-episode psychosis and therapeutic options
Khan, M. M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104919 · Cited by 5
In silico clinical trials for anti-aging therapies
Menéndez, J. A., Cuyàs, E., Folguera-Blasco, N., Verdura, S., Martín-Castillo, B., Joven, J., & Alarcón, T. (2019) · Aging · doi:10.18632/aging.102180 · Cited by 5
A low coefficient of variation in hepatic triglyceride concentration in an inbred rat strain
Shimoda, T., Hori, S., Maegawa, K., Takeuchi, A., Lee, Y., Joe, G., Tanaka, Y., Shimizu, H., & Ishizuka, S. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01320-9 · Cited by 7
Gee, S. E., Ma’ayeh, M., Kniss, D. A., Landon, M. B., Gabbe, S. G., & Rood, K. M. (2021) · American Journal of Perinatology · doi:10.1055/s-0041-1740250 · Cited by 6
Utility of Aspirin Therapy in Patients With the Cardiometabolic Syndrome and Diabetes
Gardner, M., Palmer, J. C., Manrique, C. M., Lastra, G., Gardner, D. W., & Sowers, J. R. (2009) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00037.x · Cited by 5
Pharmacological Prevention of Type 2 Diabetes
Scheen, A. J. (2008) · Wiley eBooks · doi:10.1002/9780470779750.ch29 · Cited by 6
Epidemiology and geography of type 2 diabetes mellitus
Qiao, Q., Williams, D. E., Imperatore, G., Narayan, K. M. V., & Tuomilehto, J. O. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch3 · Cited by 9
Bau, J. T., & Kurz, E. U. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.011 · Cited by 4
Prasad, S. M. V. K., Kommu, S., Dinesh Yadav, D. M., Kondeti, S., Kalashikam, R. R., & Natarajan, S. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2021-0061 · Cited by 4
Obesity, Insulin Resistance, and Inflammaging
Itariu, B. K., & Stulnig, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397803-5.00013-7 · Cited by 5
Hupfeld, C. J., & Olefsky, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00040-8 · Cited by 9
Chapter 14 Insulin resistance, inflammation, and the IKK/IκB/NF-κB pathway
Bhatt, B. A., & O'Doherty, R. M. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05014-9 · Cited by 5
Inflammatory Pathways Linked to Beta Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_30-2 · Cited by 6
Molecular Mechanisms of Insulin Resistance
Draznin, B. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_6 · Cited by 4
Jing, F., Zhou, Y., Wang, H., Yin, X., & Zhang, Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104819 · Cited by 5
The Relationship Among Obesity, Inflammation, and Insulin Resistance
Bastard, J., & Fève, B. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch17 · Cited by 6
Assessment of Insulin Sensitivity
Szendroedi, J., Phielix, E., & Roden, M. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch6 · Cited by 5
Atherogenesis and Coronary Heart Disease
Tracy, R. P. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1001 · Cited by 4
Dietary Activation of AMP-Activated Protein Kinase (AMPK) to Treat Insulin Resistance
Sears, B., & Saha, A. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103787 · Cited by 6
Insulin and the Physiology of Carbohydrate Metabolism
Pereira, S., & Giacca, A. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_1 · Cited by 4
A New Activator of Hepatocyte CaMKII in Fasting and Type 2 Diabetes
Özcan, L., & Tabas, I. A. (2018) · Diabetes · doi:10.2337/dbi18-0026 · Cited by 3
Aspirin-Mediated Reduction of Glucose Level and Inflammation in Drosophila melanogaster
Azmin, M. N., Habibie, H., Filmaharani, F., Roosevelt, A., Nurhidayah, A., Pratama, M. R., Hardiyanti, W., Latada, N. P., Mudjahid, M., Yuliana, D., et al. (2025) · ACS Omega · doi:10.1021/acsomega.4c11509 · Cited by 6
Cell-mediated immunity to insulin: A new criterion for differentiation of diabetes mellitus?
Asfandiyarova, N. S. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.11.018 · Cited by 3
Kinase-dependent pathways and the development of insulin resistance in hepatocytes
Rondinone, C. M. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.2.195 · Cited by 4
Ledwidge, M. T., Ryan, F., Kerins, D. M., O’Connell, D. P., Cefali, G., Harmon, S., Jones, M., & Gilmer, J. F. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.016 · Cited by 3
De l'obésité au diabète de type 2 : épidémiologie et physiopathologie
Fumeron, F. (2005) · Sciences des Aliments · doi:10.3166/sda.25.339-347 · Cited by 4
Dervisevic, M., Dimitrovska, M., Cipanovska, N., Dinevska-Ќovkarovska, S., & Miova, B. (2018) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2018.12.005 · Cited by 3
Serum Heparanase: A New Clinical Biomarker Involved in Senile Metabolic Inflammatory Syndrome
Zhou, X., Wang, Q., Mei, G., Wang, J., Yu, Z., Hu, Y., Guo, X., Zhang, H., Xu, X., He, C., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291612 · Cited by 5
The Mechanisms of Insulin Action
White, M. F., Copps, K. D., Özcan, U., & Tseng, Y. D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00034-4 · Cited by 3
Hypoglycemia after exposure of diclofenac medication
Falhammar, H., Törring, O., Larsson, M., & Nathanson, D. (2022) · Endocrine · doi:10.1007/s12020-022-03252-z · Cited by 4
Type 2 diabetes and insulin resistance: an hepatocentric phenomenon?
D’Alessio, D. A., Lê, K., & Tappy, L. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000172584.32632.b0 · Cited by 3
Lindsay, R. S. (2006) · CRC Press eBooks · doi:10.1201/b13359-7 · Cited by 3
Shi, X., Sheng, Y., Cao, D., Shi, N., Zhang, G., & Wang, F. (2025) · The FASEB Journal · doi:10.1096/fj.202403152r · Cited by 3
Ke, L., Zhao, L., & Jiang, S. (2025) · Medicine · doi:10.1097/md.0000000000046877 · Cited by 2
From Painkillers to Antidiabetics: Structural Modification of NSAID Scaffolds for Drug Repurposing
Gogić, A., Nikolić, M. V., Nedeljković, N. V., Zdravkovic, N. D., Vesović, M. Ž., & Živanović, A. S. (2026) · Future Pharmacology · doi:10.3390/futurepharmacol6010002 · Cited by 2
Kressler, J., Mendez, A. J., Betancourt, L. F., & Nash, M. S. (2023) · Topics in Spinal Cord Injury Rehabilitation · doi:10.46292/sci22-00033 · Cited by 2
Ahmad, S., Akhtar, S., Kamal, M. A., & Farooqui, A. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998307764240909114007 · Cited by 4
Hernández, J. L. G. (2020) · Revista CONAMED · doi:10.35366/95983 · Cited by 2
KİSMİROĞLU, C., & Yaman, M. (2020) · European Journal of Science and Technology · doi:10.31590/ejosat.746132 · Cited by 2
Prevention of β-Cell Destruction in Autoimmune Diabetes: Current Approaches and Future Prospects
Sedimbi, S. K., & Sanjeevi, C. B. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_26 · Cited by 2
Aspirin and prevention of diabetes still a topic of debate
Lastra, G., & Whaley‐Connell, A. T. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.109 · Cited by 2
Emerging concept of ageing: Inflammageing
Goto, M. (2009) · Inflammation and Regeneration · doi:10.2492/inflammregen.29.249 · Cited by 3
Baltazar, M. T., Dinis‐Oliveira, R. J., Bastos, M. D. L., Duarte, J. A., & Carvalho, F. D. (2014) · Toxicology Research · doi:10.1039/c3tx50102g · Cited by 2
Cellular Mechanisms of Insulin Action
Ciaraldi, T. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_5 · Cited by 2
Atherothrombosis and the Metabolic Syndrome
Standeven, K. F., & Grant, P. J. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch12 · Cited by 3
Future anti-inflammatory metabolic and cardiovascular management of Type 2 diabetes mellitus
Laight, D. W. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.11.1683 · Cited by 2
Raghavan, R., Laight, D. W., Shaw, K. M., & Cummings, M. H. (2006) · The British Journal of Diabetes · doi:10.1177/14746514060060020501 · Cited by 5
Chronic Inflammatory Hypothesis in the Metabolic Syndrome
Fernández‐Real, J. M., & Ricart, W. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50013-9 · Cited by 2
Gut Microbes, Immunity, and Metabolism
Hsu, E. K., & Wu, G. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_16 · Cited by 1
The Effects and Treatment of Inflammation on Diabetes Mellitus and Cardiovascular Disease
Hattar, L., Mumtaz, T., Mouhayyar, C. E., Matevossian, A., & Johnstone, M. T. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_10 · Cited by 1
(2024) · Jordan Journal of Biological Sciences · doi:10.54319/jjbs/170110 · Cited by 5
Triptolide Administration Alters Immune Responses to Mitigate Insulin Resistance in Obese States
Grodsky, L., Wilson, M., Thirumurugan, R., & Komarnytsky, S. (2024) · Biomolecules · doi:10.3390/biom14040395 · Cited by 3
Mechanisms of Diabetic Atherosclerosis
Paneni, F., & Cosentino, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-17762-5_3 · Cited by 1
Drug Treatment in the Metabolic Syndrome
Karathanasis, S. K., & SCHIEBINGER, R. J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50027-9 · Cited by 1
Manganaro, M., Papoff, P., Cicchetti, R., Caresta, E., & Moretti, C. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00113.x · Cited by 1
Fat Feeding and Muscle Fat Deposition Eliciting Insulin Resistance
Kraegen, E. W., Cooney, G. J., Ye, J. M., & Furler, S. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_16 · Cited by 1
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch10 · Cited by 2
Biological and Biomedical Aspects of Metal Phenolates
Ming, L. (2014) · Wiley eBooks · doi:10.1002/9780470682531.pat0602 · Cited by 3
Epigenetic Dysregulation in Aging and Cancer
Komninou, D., & Richie, J. P. (2009) · Wiley eBooks · doi:10.1002/9783527628384.ch17 · Cited by 1
Body Size, Obesity, and Colorectal Cancer
Slattery, M. L., & McTiernan, A. (2005) · Nutrition and disease prevention · doi:10.1201/9781420026641.ch15 · Cited by 1
Role of the Adipocyte in Metabolism and Endocrine Function
Ravussin, É., & Smith, S. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00037-x · Cited by 1
Current advances in ER stress intervention therapies
Booth, L. A., Cruickshanks, N. A., Tang, Y., Bareford, M. D., Hamed, H. A., Fisher, P. B., Grant, S., & Dent, P. (2012) · Springer eBooks · doi:10.1007/978-94-007-4351-9_19
The Role of Diet in Inflammation and Metabolic Syndrome
Sears, B. (2015) · Springer eBooks · doi:10.1007/978-3-319-16853-1_1
Schroeder, J. M., Rahman, S. M., & Friedman, J. E. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05013-7
Metadata
- Authors
- Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S., Shoelson, S. E., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Joslin Diabetes Center (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Shulman, Gerald I.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-15
- Volume
- 109
- Issue
- 10
- Pages
- 1321-1326
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4246592598
- Cited by
- 557
- References
- 24
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 11 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 17 · 2016: 24 · 2015: 32 · 2014: 33 · 2013: 24 · 2012: 24
- FWCI
- 16.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Yale University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- high-dose aspirin, salicylates, type 2 diabetes, glucose metabolism, insulin resistance, IKKβ, serine kinase, fatty acid signaling, glucose turnover, hepatic glucose production, insulin-stimulated glucose uptake, hyperinsulinemic-euglycemic clamp, mixed meal tolerance test, C-reactive protein, triglycerides, cholesterol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.